| Sep 11 |
Bristol Myers Stock Rises 16% in 3 Months: Buy, Sell or Hold?
|
| Sep 11 |
Prodrugs and patents: Enhancing therapy adherence and reducing side effects
|
| Sep 11 |
Bristol-Myers Squibb declares $0.60 dividend
|
| Sep 10 |
Bernie Sanders Says If You're Poor In America You'll Live 10-15 Years Less: 'Anybody Else See A Problem With That?'
|
| Sep 9 |
Bristol Myers Squibb: Momentum Still Promising Through H2 2024, Turnaround Likely Prolonged
|
| Sep 9 |
Bristol Myers Squibb to Present Data at ESMO Demonstrating Ongoing Leadership in Immuno-Oncology and Progression of Assets from Its Differentiated Research Platforms
|
| Sep 8 |
2 Unstoppable Dividend Growth Stocks You Can Buy Now With $100
|
| Sep 7 |
Bristol-Myers Squibb: Shares Getting Closer To The Tipping Point (Rating Downgrade)
|
| Sep 6 |
Bristol-Myers Squibb: A Better Earnings Outlook, Stronger Momentum Heading Into 2025
|
| Sep 6 |
Bristol-Myers Squibb Company (BMY) Wells Fargo 2024 Healthcare Conference (Transcript)
|
